FOLH1 and neoplasm: In the consensus published by the SNMMI [26], it is indicated that PSMA PET/CT scan should be performed to confirm the expression of the target receptor in tumor lesions since RLT will only be effective in “PSMA-positive” lesions and assess the likelihood of response to it.